Supernus Pharmaceuticals
SUPN
#5037
Rank
A$2.60 B
Marketcap
A$44.65
Share price
1.78%
Change (1 day)
-36.99%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2026 (TTM): -A$52.43 Million

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are A$0.86 Billion. In 2025 the company made an earning of -A$63.44 Million a decrease over its 2024 earnings that were of A$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$52.43 Million-17.36%
2025 -A$63.44 Million-152.66%
2024 A$0.12 B1446.62%
2023 A$7.78 M-92.36%
2022 A$0.10 B-29.8%
2021 A$0.14 B-49.79%
2020 A$0.28 B12.99%
2019 A$0.25 B7.58%
2018 A$0.23 B54.9%
2017 A$0.15 B84.25%
2016 A$83.32 M202.27%
2015 A$27.56 M-462.04%
2014 -A$7.62 Million-94%
2013 -A$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.12 B-51,828.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$10.84 B-20,044.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$52.23 B-96,171.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.02 B-31,411.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
-A$0.32 Billion 485.87%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
A$2.28 B-4,299.11%๐Ÿ‡บ๐Ÿ‡ธ USA